Aldeyra Therapeutics, Inc. (ALDX)
0.5603
-0.10
(-14.99%)
USD |
NASDAQ |
Oct 30, 16:00
0.5601
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics 30-Day Average Daily Volume : 1.633M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.633M |
| October 29, 2026 | 1.615M |
| October 28, 2026 | 1.615M |
| October 27, 2026 | 1.617M |
| October 26, 2026 | 1.611M |
| October 23, 2026 | 1.624M |
| October 22, 2026 | 1.649M |
| October 21, 2026 | 1.644M |
| October 20, 2026 | 1.641M |
| October 19, 2026 | 1.610M |
| October 16, 2026 | 1.598M |
| October 15, 2026 | 1.557M |
| October 14, 2026 | 1.532M |
| October 13, 2026 | 1.495M |
| October 12, 2026 | 1.463M |
| October 09, 2026 | 1.436M |
| October 08, 2026 | 1.422M |
| October 07, 2026 | 1.399M |
| October 06, 2026 | 1.371M |
| October 05, 2026 | 1.114M |
| October 02, 2026 | 916590.5 |
| October 01, 2026 | 872061.9 |
| September 30, 2026 | 864421.0 |
| September 29, 2026 | 832804.5 |
| September 28, 2026 | 677184.8 |
| Date | Value |
|---|---|
| September 25, 2026 | 670867.1 |
| September 24, 2026 | 694602.2 |
| September 23, 2026 | 697957.8 |
| September 22, 2026 | 692633.3 |
| September 21, 2026 | 707224.2 |
| September 18, 2026 | 729764.6 |
| September 17, 2026 | 736814.0 |
| September 16, 2026 | 751071.8 |
| September 15, 2026 | 757205.0 |
| September 14, 2026 | 755576.7 |
| September 11, 2026 | 735860.5 |
| September 10, 2026 | 701985.8 |
| September 09, 2026 | 708418.1 |
| September 08, 2026 | 720836.4 |
| September 04, 2026 | 737850.8 |
| September 03, 2026 | 759187.4 |
| September 02, 2026 | 787376.1 |
| September 01, 2026 | 806982.2 |
| August 31, 2026 | 828477.1 |
| August 28, 2026 | 849662.4 |
| August 27, 2026 | 870416.7 |
| August 26, 2026 | 947741.6 |
| August 25, 2026 | 962213.0 |
| August 24, 2026 | 975233.1 |
| August 21, 2026 | 1.003M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Prime Medicine, Inc. | 5.497M |
| Arrowhead Pharmaceuticals, Inc. | 1.853M |
| Oncolytics Biotech, Inc. | 1.292M |
| Sangamo Therapeutics, Inc. | 1.549M |
| Sarepta Therapeutics, Inc. | 2.637M |